Evaluation of the effect Kay on Carpal Tunnel Syndrome

Not Applicable

Recruiting

• Conditions: Carpal tunnel syndrome.; Carpal tunnel syndrome; G56.0

• Registration Number: IRCT20201130049540N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

Patients of both sexes in the age range of 20 to 60 years
Clinically diagnosed CTS by a specialist
Confirmed mild to moderate CTS by electrodiagnosis report
Signing the informed consent form and accept the terms of participation in the study

Exclusion Criteria

History of trauma, diabetes and thyroid disorders, collagen vascular diseases such as rheumatoid arthritis, scleroderma, amyloidosis, lupus and synchronization with other tenosynovitis certified by rheumatologist
Pregnancy
Surgery in carpal tunnel region
Evidence of cervical radiculopathy in electrodiagnosis
History of recent use of corticosteroids and analgesics (due to other diseases)
History of severe trauma or wrist fracture
History of direct injection into the carpal tunnel in the test hand
Drug abuse
Recurrent carpal tunnel syndrome

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensory Symptoms in CTS. Timepoint: The first day, the twenty-third day. Method of measurement: Standard Boston questionnaire.;Functional status of hand. Timepoint: The first day, the twenty-third day. Method of measurement: Standard Boston questionnaire.

Secondary Outcome Measures

Name	Time	Method
Intensity of pain. Timepoint: The first day, the twenty-third day. Method of measurement: Visual Analogue Scale.